Treatment of Clostridium difficile infection

Current Treatment Options in Gastroenterology

Volumn 7, Issue 3, 2004, Pages 235-239

  Stroehlein, John R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; COLESTYRAMINE; IMMUNOGLOBULIN; METRONIDAZOLE; PROBIOTIC AGENT; VANCOMYCIN;

ABDOMINAL PAIN; ANGINA PECTORIS; BACTERIAL INFECTION; BILE; CHILL; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE; COLITIS; COLON FLORA; DIARRHEA; DISEASE SEVERITY; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG HYPERSENSITIVITY; DRUG TISSUE LEVEL; DYSGEUSIA; FEVER; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; LONG TERM CARE; NAUSEA; NEUROPATHY; RECURRENT INFECTION; RELAPSE; REVIEW; SACCHAROMYCES BOULARDII;

EID: 3142550779     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0044-y     Document Type: Review

References (27)

1. Bartlett JG, Chang TW, Gurwith M, et al.: Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978, 298:531-534.
2. Larson HE, Price AB, Honour P, Borriello SP: Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978, 1:1063-1066.
3. Kelly CP, Pothoulakis C, LaMont JT: Clostridium difficile colitis. N Engl J Med 1994, 330:257-262.
4. Borriello SP: The influence of the normal flora on Clostridium difficile colonisation of the gut. Ann Med 1990, 22:61-67.
5. Fekety R, McFarland LV, Surawicz CM, et al.: Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997, 24:324-333.
6. McFarland LV, Mulligan ME, Kwok RY, Stamm WE: Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989, 320:204-210.
7. Johnson S, Gerding DN, Olson MM, et al.: Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990, 88:137-140.
8. Johnson S, Adelmann A, Clabots CR, et al.: Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis 1989, 159:340-343.
9. Surawicz CM, Elmer GW, Speelman P, et al.: Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989, 96:981-988,
10. Szajewska H, Kotowska M, Mrukowicz JZ, et al.: Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001, 138:361-365.
11. Gorbach SL, Chang TW, Goldin B: Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987, 2:1519.
12. Pothoulakis C, Kelly CP, Joshi MA, et al.: Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993, 104:1108-1115.
13. Kimmey MB, Elmer GW, Surawicz CM, McFarland LV: Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Dig Dis Sci 1990, 35:897-901.
14. Surawicz CM, McFarland LV, Elmer G, Chinn J: Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 1989, 84:1285-1287.
15. Lewis SJ, Freedman AR: Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998, 12:807-822.
16. Schwan A, Sjolin S, Trottestam U, Aronsson B: Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984, 16:211-215.
17. Tvede M, Rask-Madsen J: Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989, 1:1156-1160.
18. Tedesco F, Markham R, Gurwith M, et al.: Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet 1978, 2:226-228.
19. Fekety R, Silva J, Kauffman C, et al.: Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 1989, 86:15-19.
20. Teasley DG, Gerding DN, Olson MM, et al.: Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet 1983, 2:1043-1046.
21. Chang TW, Gorbach SL, Bartlett JG, Saginur R: Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin. Gastroenterology 1980, 78:1584-1586.
22. Kelly CP: Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol 1996, 8:1048-1053.
23. Warny M, Vaerman JP, Avesani V, Delmee M: Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994, 62:384-389.
24. Aronsson B, Granstrom M, Mollby R, Nord CE: Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea. Infection 1985, 13:97-101.
25. Leung DY, Kelly CP, Boguniewicz M, et al.: Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991, 118(4 pt 1):633-637.
26. Salcedo J, Keates S, Pothoulakis C, et al.: Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 1997, 41:366-370.
27. Saginur R, Hawley CR, Bartlett JG: Colitis associated with metronidazole therapy. J Infect Dis 1980, 141:772-774.